Počet záznamů: 1
Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress
SYS 0369512 LBL 02318^^^^^2200325^^^450 005 20240103200053.6 014 $a 000293922300007 $2 WOS 017 70
$a 10.1007/s10456-011-9213-5 $2 DOI 100 $a 20120301d m y slo 03 ba 101 0-
$a eng $d eng 102 $a NL 200 1-
$a Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress 215 $a 15 463 -1
$1 001 cav_un_epca*0361730 $1 011 $a 0969-6970 $e 1573-7209 $1 200 1 $a Angiogenesis $v Roč. 14, č. 3 (2011), s. 293-307 610 0-
$a Galectin-1 inhibitor 610 0-
$a oxidative stress 610 0-
$a angiogenesis 700 -1
$3 cav_un_auth*0277422 $a Ito $b K. $y AU $4 070 701 -1
$3 cav_un_auth*0277423 $a Scott $b S.A. $y AU $4 070 701 -1
$3 cav_un_auth*0277424 $a Cutler $b S. $y AU $4 070 701 -1
$3 cav_un_auth*0243250 $a Dong $b L.-F. $y AU $4 070 701 -1
$3 cav_un_auth*0239896 $a Neužil $b Jiří $i Laboratoř molekulární terapie $j Laboratory of Molecular Therapy $p BTO-N $w Development of Diagnostic and Therapeutic Procedures $4 070 $T Biotechnologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0277425 $a Blanchard $b H. $y AU $4 070 701 -1
$3 cav_un_auth*0226812 $a Ralph $b S.J. $y AU $4 070
Počet záznamů: 1